Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1995; 74(01): 345-351DOI: 10.1055/s-0038-1642700 Symposium Platler Glycoproteins and Genetic Disorders Schattauer GmbH Stuttgart Polymorphisms of Human Platelet Membrane Glycoproteins: Structure and Clinical Significance Alan T Nurden URA 1464 CNRS, Hôpital Cardioiogique, Pessac, France › Author Affiliations Recommend Article Abstract PDF Download Buy Article PDF (524 kb) References References 1 Kieffer N, Phillips DR. Platelet membrane glycoproteins: functions in cellular interactions. Ann Rev Cell Biol. 1990. 6 329-357 2 Nurden AT. Human platelet membrane glycoproteins. In: Haemostasis and Thrombosis, Edition III. Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds. Churchill Livingstone; Edinburgh: 1994: 115-165 3 Roth GJ. Developing relationships: Arterial platelet adhesion, glycoprotein lb, and leucine-rich glycoproteins. Blood 1991; 7: 5-19 4 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagulation and Fibrinolysis 1994; 5: 97-119 5 Hess D, Schaller J, Rickli EE, Clemetson KJ. Identification of the disulphide bonds in human platelet glycocalicin. Eur J Biochem 1991; 199: 389-393 6 Lanza F, Morales M, de la Salle C, Cazenave J-P, Clemetson KJ, Shimomura T, Phillips DR. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation J Biol Chem 1993; 268: 20801-20807 7 Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE G Kr. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-369 8 Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the alpha chain of platelet glycoprotein lb that participates in von Willebrand binding. J Biol Chem 1990; 265: 274-280 9 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin interactive domains cm human platelet glycoprotein lb. Thromb Haemostas 1990; 63: 122-126 10 Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton II JW, Krutzsch H. High-affinity α-thrombin binding to platelet glycoprotein Iβα: Identification of two binding domains. Proc Natl Acad Sci USA 1994; 91: 6334-6338 11 Moroi M, Jung SM, Yoshida N. Genetic polymorphism of platelet glycoprotein lb. Blood 1984; 64: 622-629 12 Lopez JA, Ludwig EH, McCarthy BY. Polymorphism ofhuman glycoprotein Iβα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992; 267: 10055-10061 13 Kunicki TJ, Newman PJ. The molecular immunology of human platelet proteins. Blood 1992; 80: 1386-1404 14 Kuijpers RW A M, Faber NM, Cuypers HT M, Ouwehand WH, von dem Borne AE G Kr. The N-terminal globular domain of human platelet glycoprotein Iβα has a methionine 145/threonine 145 amino acid polymorphism which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-384 15 von dem Borne AE G, Décary F. ICSH/ISBT working party on platelet serology. Nomenclature of platelet-specific antigens. Vox Sang 1990; 58: 176-176 16 Simsek S, Bleeker PM M, van der Schoot CE, von dem Borne AE G Kr. Association of a variable number of tandem repeats (VNTR) in glycoprotein Iβα and HPA-2 alloantigens. Thromb Haemostas 1994; 72: 757-761 17 George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 1984; 311: 1084-1098 18 Bray PF. Inherited diseases of platelet glycoproteins: Considerations for rapid molecular characterization. Thromb Haemostas 1994; 72: 492-502 19 Ware J, Russell SR, Marchese P, Murata M, Mazzucato M, De Marco L, Ruggeri ZM. Point mutation in a leucine-rich repeat of platelet glycoprotein Iβα resulting in the Bemard-Soulier syndrome. J din Invest 1993; 92: 1213-1220 20 Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Iβα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bemard-Soulier disease. Blood 1992; 79: 439-446 21 Russell SD, Roth GJ. Pseudo-von Willebrand disease: A mutation in the platelet glycoprotein Iβα gene associated with a hyperactive surface receptor. Blood 1993; 81: 1787-1791 22 Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the a chain of platelet glycoprotein lb in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-4765 23 Santoso S, Kalb R, Kiefel V, Mueller-Eckhardt C, Newman PJ. The human platelet alloantigens, Bra and Br6 are associated with a single amino acid polymorphism on glycoprotein la (integrin α2 subunit). J Clin Invest 1993; 92: 2427-2432 24 Kunicki TJ, Orchekowski R, Annis D, Honda Y. Variability of integrin a2b1activity on human platelets. Blood 1993; 82: 2693-2703 25 Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GP Illa. A disulphide pattern for the β-subunits of the integrin family. Biochem J 1991; 274: 63-71 26 Villa-Garcia M, Li L, Riely G, Bray PF. Isolation and characterisation of a TATA-less promoter for the human β3 integrin gene. Blood 1994; 83: 668-676 27 Plow EF, D’Souza SE, Ginsberg MH. Ligand binding to GPIIb-IIIa: A status report. Sem Thromb Hemostas 1992; 18: 324-332 28 Charo IF, Nannizzi L, Phillips DR, Hsu MA, Scarborough RM. Inhibition of fibrinogen binding to GPIIb-IIIa by a GPIIIa peptide. J Biol Chem 1991; 266: 1415-1421 29 Walchshofer S, Ghali D, Fink M, Panzer-Grümayer ER, Panzer S. A rare leucine40/Arginine40polymorphism on platelet glycoprotein Ilia is linked to the human platelet antigen lb. Vox Sang 1994; 67: 231-234 30 Wang R, Furihata K, McFarland JG, Friedman K, Aster RH, Newman PJ. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein Ilia is responsible for the foimation of the Pena/ Penb alloantigen system. J Clin Invest 1992; 90: 2038-2043 31 Wang R, McFarland JG, Kekomaki R, Newman PJ. Amino acid 489 is coded by a mutational “hot spot” on the beta3 integrin chain: the CA/TU human platelet alloantigen system. Blood 1993; 82: 3386-3391 32 Kuijpers RW A M, Simsek S, Faber NM, Goldschmeding R, van Wermerkerken RK V, von dem Borne AE G Kr. Single point mutation in human glycoprotein Ilia is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia. Blood 1993; 81: 70-76 33 Santoso S, Kalb R, Kroll H, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ. A point mutation leads to an unpaired cysteine residue and a molecular weight polymoiphism of a functional platelet β3 integrin subunit. J Biol Chem 1994; 269: 8439-8444 34 Lyman S, Aster RH, Visentin GP, Newman PJ. Polymorphism of human platelet membrane glycoprotein lib as sociated with the Baka/Bakb alloantigen system. Blood 1990; 75: 2343-2348 35 George JN, Nurden AT, Caen JP. Glanzmann’s thrombasthenia: The spectrum of clinical disease. Blood 1990; 75: 1383-1395 36 Ginsberg MH, Frelinger AL, Lam SC T, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein Ilb-IIIa with conformation-specific monoclonal antibodies. Blood 1990; 76: 2017-2023 37 Loftus JC, O’Toole TE, Plow EF, Glass A, Frelinger III AL, Ginsberg MH. A β3 integrin mutation abolishes ligand binding and alters divalent cation- dependent conformation. Science 1990; 249: 915-918 38 Bajt ML, Ginsberg MH, Frelinger III AL, Bemdt MC, Loftus JC. A spontaneous mutation of integrin αIlbβ3(platelet glycoprotein Ilb-IIIa) helps define a ligand binding site. J Biol Chem 1992; 267: 3789-3794 39 Lanza F, Stierlé A, Fournier D, Morales M, André G, Nurden AT, Cazenave J-P. A new variant of Glanzmann’s thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein Ilb-IIIa complexes and a glycoprotein Illa214Arg ->214Trp mutation J Clin Invest 1992; 89: 1995-2004 40 Djaffar I, Rosa J-P. A second case of variant of Glanzmann’s thrombasthenia due to substitution of platelet GP Ilia (integrin β3) Arg214 by Trp. Hum Mol Gen 1993; 2: 2179-2180 41 Chen Y-P, Djaffar I, Pidard D, Steiner B, Cieutat A-M, Caen JP, Rosa J-P. Ser-752-> Pro mutation in the cytoplasmic domain of integrin b3 subunit and defective activation of platelet integrin αIlbβ3 (glycoprotein Ilb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-10173 42 Peyruchaud O, Nurden AT, Bourre F. Use of PCR-SSCP to screen the exons of the GP lib and GP Ilia genes of a variant with Glanzmann’s thrombasthenia: A mutation in the nucleotide sequence for the GFFKR cytoplasmic domain of the integrin subunit αIlb (GP lib). Abstr, this congress. 43 Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann’s thrombasthenia: New Insights from an historical perspective. Sem Hematol 1994; 31: 301-311 44 Gawaz MP, Loftus JC, Bajt ML, Frojmovic MM, Plow EF, Ginsberg MH. Ligand binding mediates integrin (platelet GP Ilb-IIIa) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 1991; 88: 1128-1134 45 Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-2796 46 Nurden P, Savi P, Heilmann E, Bihour C, Herbert J-M, Maffrand J-P, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on GP Ilb-IIIa complex function. J Clin Invest. In press 47 Vu T-K, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068 48 Nurden P, Nurden AT. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction. Ballières Clinical Haematology 1993; 6: 653-690 49 Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with x-linked nephrogenic diabetes insipidus. Nature Genetics 1992; 2: 103-108 50 Jin Y, Dietz HC, Nurden AT, Bray PF. SSCP is a rapid and effective method for the identification of mutations and polymorphisms in the gene for GP Illa. Blood 1993; 82: 2281-2288 51 Peyruchaud O, Nurden A, Bourre F. Non-radioactive SSCP for genotyping human platelet alloantigens. Br J Haematol. 1995 In Press 52 Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644 53 Wenzel K, Felix S, Kleber FX, Brachold R, Menke T, Schattke S, Schulte KL, Gläser C, Rohde K, Baumann G, Speer A. E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Gen 1994; 3: 1935-1937
